Peter Pertel Selected Research

Dizziness (Lightheadedness)

10/2014

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Pertel Research Topics

Disease

3	Infections 10/2021 - 11/2005
3	Malaria 10/2021 - 10/2014
3	Diarrhea 03/2015 - 11/2012
2	Clostridium Infections 03/2015 - 03/2015
1	Parasitic Diseases (Parasitic Disease) 10/2021
1	Hypersensitivity (Allergy) 01/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2016
1	Vivax Malaria 01/2016
1	Hematoma 10/2014
1	Dizziness (Lightheadedness) 10/2014
1	Headache (Headaches) 10/2014
1	Nausea 10/2014
1	Community-Acquired Infections 08/2006
1	Intraabdominal Infections 08/2006
1	Sinusitis 04/2006
1	Maxillary Sinusitis 04/2006

Drug/Important Bio-Agent (IBA)

3	ganaplacideIBA 10/2021 - 11/2014
3	LFF571IBA 03/2015 - 11/2012
3	Moxifloxacin (Avelox)FDA Link 08/2006 - 11/2005
2	Antimalarials (Antimalarial Agents)IBA 01/2016 - 11/2014
2	Vancomycin FDA LinkGeneric 03/2015 - 03/2015
2	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 08/2006 - 11/2005
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 08/2006 - 11/2005
2	Amoxicillin (Wymox)FDA LinkGeneric 08/2006 - 11/2005
1	proguanil drug combination atovaquone (malarone)FDA Link 10/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 10/2021
1	AntibodiesIBA 01/2016
1	NITD 609IBA 10/2014

Therapy/Procedure

2	Therapeutics 03/2015 - 04/2006
1	Aftercare (After-Treatment) 01/2016
1	Catheters 10/2014